Incidence and structure of benign breast diseases after surgical treatment of gynecological diseases

We validate the therapeutic tactics in benign mammary dysplasia (BMD) in women after surgical treatment of gynecological diseases. For the decision of this challenge we have examined 518 women aged 18 to 49 years, seeking in breast service. We sequentially assessed gynecological and breast status in all these women under single screening. It was found that patients with preserved ovaries after surgical treatment of gynecological diseases have high risk for BMD. Subtotal or total hysterectomy with preservation of ovaries leads to increase risk of recurrence of localized forms BMD. Complex treatment of BMD in women after surgical treatment of gynecological diseases, differentially selected contraception, restoration of genital tract eubiosis, and immune resistance can reduce the frequency of BMD by 3 times, and the reccurence rate of localized forms by 5 times.

benign mammary dysplasia, fibrocystic breast disease, gynecological disease, surgical treatment, ovaries